About Heparinex

About company

Heparinex, L.L.C. is a biopharmaceutical company focused on the novel recombinant synthesis of compounds for (1) the growing anticoagulation market and associated markets and (2) the dermal filler market. Leading carbohydrate chemist/glycobiologist Dr. Paul DeAngelis originally discovered and patented Heparinex’s core technology platforms of proprietary carbohydrate production.